ProMIS Neurosciences (PMN) announced important progress in the PRECISE-AD Phase 1b clinical trial with the dosing of multiple patients with its ...

Rapid Enrollment and Dosing of First Patients Encouraging and Underscores Unmet Need for Better Treatment Options for Alzheimer’s Disease ...

BURLINGTON, Mass. (AP) — BURLINGTON, Mass. (AP) — Minerva Neurosciences Inc. (NERV) on Tuesday reported a loss of $4.3 million in its fourth quarter. On a per-share basis, the Burlington, ...

Minerva Neurosciences (NASDAQ:NERV – Get Free Report) is anticipated to post its quarterly earnings results before the market ...

StockNews.com began coverage on shares of Minerva Neurosciences (NASDAQ:NERV – Get Free Report) in a research report issued to clients and investors on Saturday. The firm set a “sell” rating on the ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Jupiter, Florida, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical ...

MAHE, Manipal Introduces Integrated B.Sc. to M.Sc. Program in Clinical and Computational Neurosciences - The Manipal Academy ...

Human evolution has revolved around food, from identifying and foraging for it to growing and preparing it. Carnegie Mellon ...

BURLINGTON, Mass., Feb. 25, 2025(Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today reported business up ...

Klotho Neurosciences, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates ...